StockComparison Logo
vs

GSK vs BN

Comparison between GSK Plc (GSK, Company) and Brookfield Corporation - Class A (BN, Company).

GSK is from the Healthcare sector, while BN is from the Financial Services sector.

5-Year PerformanceBN has outperformed GSK, delivering a return of +8.4% compared to +4.9%

GSK vs BN - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
GSK
$105B
Winner
BN
$105B
Max Drawdown
Winner
GSK
64.03%
BN
73.40%
Sharpe Ratio
Winner
GSK
1.40
BN
-0.04
5Y Beta
Winner
GSK
0.24
BN
1.43
Industry
GSK
Drug Manufacturers - General
BN
Asset Management
P/E Ratio
Winner
GSK
16.34
BN
78.89
Forward P/E
GSK
20.79
Winner
BN
11.89
PEG Ratio
Winner
GSK
0.37
BN
0.67
Dividend Yield
Winner
GSK
3.53%
BN
0.56%
5Y Dividends CAGR
Winner
GSK
1.92%
BN
-9.86%
5Y EPS CAGR
Winner
GSK
1.36%
BN
-1.09%
Debt to Equity
Winner
GSK
103.36%
BN
571.67%
Free Cash Flow Yield
Winner
GSK
8.93%
BN
-7.84%
P/S Ratio
GSK
3.10
Winner
BN
1.26
P/B Ratio
GSK
4.33
Winner
BN
2.56

GSK vs BN - Historical Returns

Returns include dividend reinvestment.

1M
GSK
-1.73%
Winner
BN
+0.05%
3M
Winner
GSK
+4.20%
BN
-5.17%
6M
GSK
-11.86%
Winner
BN
-2.40%
1Y
Winner
GSK
+47.31%
BN
-1.67%
5Y(CAGR)
GSK
+4.89%
Winner
BN
+8.42%
10Y(CAGR)
GSK
+4.01%
Winner
BN
+14.84%
Max(CAGR)
GSK
+3.16%
Winner
BN
+18.29%

GSK vs BN - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearGSKBN
2026+6.96%-5.37%
2025+50.62%+20.33%
2024-6.27%+48.89%
2023+9.25%+28.19%
2022-32.73%-34.35%
2021+23.62%+56.21%
2020-17.52%+8.87%
2019+30.36%+54.24%
2018+9.29%-9.63%
2017-3.80%+33.02%
2016+1.52%+10.47%
2015+0.48%-4.72%
2014-14.73%+31.81%
2013+26.97%+9.81%
2012-0.75%+33.58%
2011+22.51%-16.44%
2010-3.72%+52.46%
2009+20.27%+48.15%
2008-21.93%-55.15%
2007-2.77%+14.67%
2006+6.93%+42.45%
2005+9.96%+43.00%
2004+5.08%+77.08%
2003+25.04%+56.79%
2002-22.83%+22.19%
2001-9.58%+34.46%
2000+5.67%+13.72%
1999-5.78%+3.38%

GSK vs BN Drawdown Comparison

The maximum drawdown for GSK was -50.11%, occurring on Sep 27, 2022. Recovery took 935 trading sessions.

The maximum drawdown for BN was -71.78%, occurring on Mar 9, 2009. Recovery took 1438 trading sessions.

The current GSK drawdown is -13.23%. The current BN drawdown is -10.26%.

RankGSKBN
#1-50.11%
Apr 13, 2022 - Jan 6, 2026
-71.78%
May 22, 2007 - Feb 6, 2013
#2-49.64%
Apr 20, 2007 - Apr 18, 2012
-51.42%
Feb 20, 2020 - Mar 17, 2021
#3-45.23%
Apr 25, 2000 - Nov 11, 2005
-41.86%
Oct 28, 2021 - Jul 31, 2024
#4-32.56%
Jan 17, 2020 - Dec 10, 2021
-28.63%
Apr 15, 2015 - May 2, 2017
#5-27.97%
Mar 4, 2014 - Sep 3, 2019
-27.85%
Jan 30, 2025 - Jun 30, 2025
#6-26.98%
Nov 5, 1999 - Apr 11, 2000
-22.05%
Jan 6, 2026 - Mar 20, 2026
#7-18.51%
Feb 18, 2026 - Jun 2, 2026
-21.46%
Jun 7, 2002 - May 6, 2003
#8-14.45%
Jan 18, 2022 - Apr 7, 2022
-20.13%
Jan 10, 2000 - Aug 24, 2000
#9-10.52%
May 16, 2006 - Feb 13, 2007
-19.03%
Aug 23, 2001 - Dec 27, 2001
#10-10.48%
Oct 4, 2012 - Mar 22, 2013
-18.08%
Oct 1, 2018 - Feb 26, 2019
#11-8.45%
May 28, 2013 - Nov 1, 2013
-17.84%
Mar 30, 2004 - Jun 8, 2004
#12-8.43%
Apr 11, 2000 - Apr 25, 2000
-15.94%
Nov 23, 2004 - Aug 25, 2005
#13-8.16%
Nov 11, 2005 - Mar 8, 2006
-13.79%
Aug 25, 2000 - Nov 15, 2000
#14-7.54%
Feb 14, 2007 - Apr 16, 2007
-13.63%
Dec 13, 2017 - Aug 16, 2018
#15-7.37%
Jan 21, 2014 - Feb 13, 2014
-12.30%
May 8, 2013 - Oct 16, 2013

Correlation

Correlation between GSK and BN is 0.83 which considered as a strong positive correlation - the stocks tend to move together.

0.83
-101

Dividend Comparison (2000 - 2026)

GSK vs BN dividend yield comparison.

YearGSKBN
20261.81%0.32%
20253.42%0.52%
20244.60%0.56%
20233.75%0.70%
20225.47%1.44%
20214.99%1.12%
20205.59%1.55%
20194.35%1.11%
20185.65%1.56%
20175.83%1.29%
20166.86%1.58%
20155.93%1.50%
20146.20%1.36%
20134.51%4.64%
20125.70%1.50%
20114.83%1.89%
20105.10%1.56%
20094.39%2.34%
20085.74%8.87%
20074.09%1.31%
20063.29%1.21%
20053.03%1.17%
20043.38%1.76%
20032.77%3.96%
20023.10%5.61%
20011.54%6.36%
20004.57%4.47%

Select Stocks to Compare